SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001104659-20-119208
Filing Date
2020-10-29
Accepted
2020-10-29 06:08:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B tm2024520d15_8a12b.htm 8-A12B 14720
  Complete submission text file 0001104659-20-119208.txt   15719
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-39676 | Film No.: 201270342
SIC: 2836 Biological Products, (No Diagnostic Substances)